Arnaud Da Cruz Paula

Arnaud Da Cruz Paula

UNVERIFIED PROFILE

Are you Arnaud Da Cruz Paula?   Register this Author

Register author
Arnaud Da Cruz Paula

Arnaud Da Cruz Paula

Publications by authors named "Arnaud Da Cruz Paula"

Are you Arnaud Da Cruz Paula?   Register this Author

23Publications

846Reads

42Profile Views

Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.

Cancer Cell 2018 12;34(6):893-905.e8

Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA; Breast Medicine Service, Department of Medicine, MSKCC, New York, NY 10065, USA; Weill-Cornell Medical College, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15356108183052
Publisher Site
http://dx.doi.org/10.1016/j.ccell.2018.11.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294301PMC
December 2018

Implications of Different Cancer Stem Cell Phenotypes in Breast Cancer.

Anticancer Res 2017 05;37(5):2173-2183

Pathology and Molecular Immunology Department, Abel Salazar Institute of Biomedical Sciences, Porto, Portugal

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11552DOI Listing
May 2017

Molecular characterization of CD44/CD24/Ck/CD45 cells in benign and malignant breast lesions.

Virchows Arch 2017 Mar 23;470(3):311-322. Epub 2017 Jan 23.

Pathology and Molecular Immunology Department, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Jorge Viterbo Ferreira Street, n° 288, 4050-313, Porto, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-017-2068-4DOI Listing
March 2017

Characterization of CD44+ALDH1+Ki-67- Cells in Non-malignant and Neoplastic Lesions of the Breast.

Anticancer Res 2016 09;36(9):4629-38

Pathology and Molecular Immunology Department, Abel Salazar Institute of Biomedical Sciences, University of Porto, Porto, Portugal Department of Pathology, Portuguese Oncology Institute, Porto, Portugal

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11013DOI Listing
September 2016

Co-expression of stem cell markers ALDH1 and CD44 in non-malignant and neoplastic lesions of the breast.

Anticancer Res 2014 Mar;34(3):1427-34

MSc. and Carlos Lopes, Department of Pathology and Molecular Immunogenetics, Institute of Biomedical Sciences Abel Salazar. Jorge Viterbo Ferreira Street, n° 288, 4050-313, Porto, Portugal.

View Article

Download full-text PDF

Source
March 2014